Sign in

CIK 0002056611 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company

Latigo Biotherapeutics, Inc.

Sign in to watch
Ticker
LTGO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
832625838
Phone
805-716-2927
Business address
1300 RANCHO CONEJO BLVD., SUITE 305, THOUSAND OAKS, CA
  1. 4 Conversion 10% owner acquired 7,325,962 shares (conversion)
  2. 4 Conversion 10% owner acquired 672,778 shares (conversion)
  3. 3 Insider Initial Statement of Ownership
  4. 4 Conversion 10% owner acquired 12,695,305 shares (conversion)
  5. 4 Open-market buy 10% owner bought 140,000 shares at $18.00 ($2,520,000)
  6. 4 Derivatives Options or other derivatives
  7. 4 Open-market buy Director bought 140,000 shares at $18.00 ($2,520,000)
  8. 4 Conversion Director acquired 12,695,305 shares (conversion)
  9. 3 Insider Initial Statement of Ownership
  10. 3 Insider Initial Statement of Ownership
  11. 3 Insider Initial Statement of Ownership
  12. 3 Insider Initial Statement of Ownership
  13. 3 Insider Initial Statement of Ownership
  14. 3 Insider Initial Statement of Ownership
  15. 3 Insider Initial Statement of Ownership
  16. 3 Insider Initial Statement of Ownership
  17. 3 Insider Initial Statement of Ownership
  18. 3 Insider Initial Statement of Ownership
  19. 3 Insider Initial Statement of Ownership
  20. 3 Insider Initial Statement of Ownership

Page 1 of 1 · 20 filings